Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

90
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
90
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

85
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
85

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hyperuricemia as an Early Indicator of Cardiovascular Risk in the General Population.

Journal of clinical medicine·2025
Same author

Cardiovascular endpoints and psychosocial challenges of lipoprotein(a) of 5726 participants in the ELITE-study over 5 years.

Lipids in health and disease·2025
Same author

Football as the champion of cardiovascular prevention: results of the randomized and interventional MY-3F study (Fit & Fun with Football after myocardial infarction or coronary artery disease).

European journal of preventive cardiology·2025
Same author

Complete revascularization versus culprit-lesion only PCI in patients with NSTEMI and multivessel disease - Design and rationale of the randomized COMPLETE-NSTEMI trial.

American heart journal·2025
Same author

Does Intra-Annular Valve Design Equal Intra-Annular Valve Design? Comparison of Two Transcatheter Aortic Valve Prostheses.

Journal of clinical medicine·2025
Same author

Pregnancy-Associated Spontaneous Coronary Dissection in a 32-Year-Old During the Third Trimester.

JACC. Case reports·2025

Related Experiment Video

Updated: Nov 3, 2025

Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease
06:39

Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease

Published on: February 18, 2020

7.0K

Latest Developments in Robotic Percutaneous Coronary Intervention.

Felix J Hofmann1, Oliver Dörr1, Florian Blachutzik1

  • 1Department of Cardiology, University of Giessen, Giessen, Germany.

Surgical Technology International
|June 3, 2021
PubMed
Summary
This summary is machine-generated.

Robotics-assisted percutaneous coronary intervention (rPCI) offers significant benefits, reducing radiation exposure and medical risks for cardiologists while maintaining high success rates. Further research is needed to fully assess its long-term patient outcomes and overcome current system limitations.

More Related Videos

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.9K
Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

19.9K

Related Experiment Videos

Last Updated: Nov 3, 2025

Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease
06:39

Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease

Published on: February 18, 2020

7.0K
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.9K
Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

19.9K

Area of Science:

  • Interventional cardiovascular medicine
  • Medical robotics

Background:

  • Interventional cardiology has advanced significantly, reducing cardiovascular morbidity and mortality.
  • Percutaneous coronary intervention (PCI) has been a cornerstone of treatment.

Purpose of the Study:

  • To review the latest developments and evidence in robotics-assisted percutaneous coronary intervention (rPCI).
  • To explore potential future applications, opportunities, and limitations of rPCI.

Main Methods:

  • Review of contemporary evidence on robotics-assisted percutaneous coronary intervention.
  • Analysis of safety, efficacy, and outcomes in various coronary procedures.

Main Results:

  • rPCI reduces radiation exposure and medical hazards for cardiologists.
  • High rates of device and procedural success with no patient disadvantage observed.
  • Improved accuracy in device implantation leading to better treatment quality.
  • rPCI demonstrates safety and efficiency even in complex coronary lesions.

Conclusions:

  • rPCI is a promising innovation in cardiology with broad applicability.
  • Current limitations include the need for large-scale randomized trials and technical system improvements.
  • Available data suggest rPCI offers potential benefits for both physicians and patients.